Skip to content
10-K

Annual Report

NEUEHEALTH, INC.

0001671284-25-000004

← back to feed
Filed
Mar 21, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 14, 2025 8.65M sh
Shares Diluted FY 2024 · Dec 31, 2024 8.23M sh
Shares Diluted FY 2024 · Dec 31, 2023 7.95M sh
Capex FY 2024 · Dec 31, 2024 $2.33M
Capex FY 2024 · Dec 31, 2023 $2.9M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$123.22M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$2.73B
Long Term Debt FY 2024 · Dec 31, 2024 $202.61M
Long Term Debt FY 2024 · Dec 31, 2023 $66.4M
Short Term Debt FY 2024 · Dec 31, 2024 $2M
Short Term Debt FY 2024 · Dec 31, 2023 $303.95M
Short Term Investments FY 2024 · Dec 31, 2024 $9.87M
Short Term Investments FY 2024 · Dec 31, 2023 $6.27M
Cash And Equivalents FY 2024 · Dec 31, 2024 $83.3M
Cash And Equivalents FY 2024 · Dec 31, 2023 $87.3M
Stockholders Equity FY 2024 · Dec 31, 2024 −$1.36B
Stockholders Equity FY 2024 · Dec 31, 2023 −$1.26B
Stockholders Equity FY 2024 · Dec 31, 2022 −$200.49M
Current Liabilities FY 2024 · Dec 31, 2024 $710.23M
Current Liabilities FY 2024 · Dec 31, 2023 $1.39B
Total Liabilities FY 2024 · Dec 31, 2024 $930.49M
Total Liabilities FY 2024 · Dec 31, 2023 $1.48B
Current Assets FY 2024 · Dec 31, 2024 $434.65M
Current Assets FY 2024 · Dec 31, 2023 $1.09B
Total Assets FY 2024 · Dec 31, 2024 $544.38M
Total Assets FY 2024 · Dec 31, 2023 $1.23B
Eps Diluted FY 2024 · Dec 31, 2024 −$22.65
Eps Diluted FY 2024 · Dec 31, 2023 −$150.94
Eps Basic FY 2024 · Dec 31, 2024 −$22.65
Eps Basic FY 2024 · Dec 31, 2023 −$150.94
Net Income FY 2024 · Dec 31, 2024 −$134.68M
Net Income FY 2024 · Dec 31, 2023 −$1.15B
Operating Income FY 2024 · Dec 31, 2024 −$107.41M
Operating Income FY 2024 · Dec 31, 2023 −$577M